Coming Q1 2027 · TechUP-Funded · HKD 600K R&D Grant

LinguaLeap: AI-Assisted Swallowing Assessment for the Elderly

The first Cantonese-first AI companion device that combines dysphagia assessment, swallowing therapy exercises, and care-home clinical reporting — in one dedicated hardware unit.

The Problem LinguaLeap Solves

Three in four nursing-home residents with dysphagia are never formally assessed. Aspiration pneumonia from unmanaged dysphagia is one of the leading preventable killers of the elderly across Asia. No FDA-cleared commercial voice-biomarker device for home-based AI dysphagia screening exists as of 2026. No eldercare hardware product globally offers Cantonese as its primary interface language.

1 in 3
Nursing-home residents has dysphagia
3 in 4
Are never formally assessed
0
FDA-cleared AI dysphagia screening devices (April 2026)

What LinguaLeap Does

AI Swallowing Assessment

Voice-biomarker and deep-learning analysis to flag swallowing risk, routing clinical alerts to speech therapists on staff — not as a diagnostic device, but as an AI-assisted wellness tracker.

Cantonese-First Interface

Designed from the ground up for Cantonese-speaking elderly in Hong Kong and the Greater Bay Area. Zero existing competitors offer Cantonese as a primary eldercare AI interface.

Clinician Dashboard

Weekly dysphagia trend reports delivered to care-home speech therapists and nurses, creating a longitudinal clinical data layer no other device provides.

SeniorDeli Integration

AI detects swallowing risk, recommends texture modification, SeniorDeli fulfills the food order, compliance is tracked, clinician receives a progress report.

Technology

LinguaLeap is built on a Raspberry Pi 5 platform (BOM ~USD 350) with a custom AI inference stack trained on Cantonese speech and swallowing biomarkers. Software runs on the same unified Supabase backend as the SeniorDeli platform and the nurse dashboard.

Platform
Raspberry Pi 5 + custom AI stack
Primary language
Cantonese (Yue Chinese)
Funding
TechUP Y06 — HKD 600,000 (December 2025)
Target launch
Q1 2027 (RCHE clinical edition)
Regulatory path
Planned: HKMD Class I registration → Class II; FDA Breakthrough Device program — application in preparation

R&D Timeline

  1. Dec 2025

    TechUP Y06 grant awarded — HKD 600,000

  2. Q1 2026

    Hardware prototype (Pi 5) + AI inference stack

  3. Q2-Q3 2026

    RCHE pilot partnerships (2-3 Hong Kong care homes)

  4. Q4 2026

    HKMD Class I registration; clinical outcome data collection

  5. Q1 2027

    Clinical edition launch to RCHE partners

  6. 2027

    FDA Breakthrough Device program — application in preparation; HKMD Class II application

Join the Waitlist

Be the first to hear about LinguaLeap's Q1 2027 launch. We are prioritising care-home partners, speech therapists, and family caregivers in Hong Kong and the Greater Bay Area.

Or email us directly at lingualeap@seniordeli.com

Frequently Asked Questions

Is LinguaLeap a medical device?
LinguaLeap is positioned as an AI-assisted wellness tracker, not a diagnostic device. All swallowing risk alerts are routed to a clinician for review. We are pursuing HKMD Class I registration initially, with a Class II clinical upgrade planned for 2027.
What languages does LinguaLeap support?
Cantonese (Yue Chinese) is the primary interface language, designed for elderly users in Hong Kong, Macau, Guangdong, and the global Cantonese diaspora. Mandarin and English support are planned for subsequent releases.
How does LinguaLeap integrate with SeniorDeli food?
When the AI flags elevated swallowing risk, the dashboard generates a texture modification recommendation aligned to IDDSI / T/SATA 094-2025 standards. Care homes can fulfil this via their existing SeniorDeli food subscription.
When can my care home pilot LinguaLeap?
We are onboarding 2-3 RCHE pilot partners in Hong Kong from Q2 2026. Email lingualeap@seniordeli.com to express interest. Pilot participants receive priority access to the Q1 2027 clinical edition at a preferred rate.

This tool provides general food texture education and IDDSI self-check support only. It is not a clinical assessment, diagnostic device, or medical advice. Consult a qualified speech-language pathologist or dietitian for medical concerns.